Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
21
LFMD Quote, Financials, Valuation and Earnings
Last price:
$5.00
Seasonality move
:
12.11%
Day range:
$4.76 - $5.17
52-week range:
$3.99 - $12.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.04x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
825.5K
1-year change:
-37%
Market cap:
$218.3M
Revenue:
$152.5M
EPS (TTM):
-$0.64
Analysts' Opinion
-
Consensus RatingLifeMD has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.00, LifeMD has an estimated upside of 138.1% from its current price of $5.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.00 representing -38.89% downside risk from its current price of $5.04.
Fair Value
-
According to the consensus of 8 analysts, LifeMD has 138.1% upside to fair value with a price target of $12.00 per share.
LFMD vs. S&P 500
-
Over the past 5 trading days, LifeMD has underperformed the S&P 500 by -9.63% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
LifeMD does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
LifeMD has grown year-over-year revenues for 24 quarters straight. In the most recent quarter LifeMD reported revenues of $53.4M.
Earnings Growth
-
LifeMD has grown year-over-year earnings for 0 quarters straight. In the most recent quarter LifeMD reported earnings per share of -$0.14.
Enterprise value:
200.7M
EV / Invested capital:
16.35x
Price / LTM sales:
1.04x
EV / EBIT:
--
EV / Revenue:
1.04x
PEG ratio (5yr expected):
--
EV / Free cash flow:
18.89x
Price / Operating cash flow:
18.89x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$173.1M
Return On Assets:
-37.89%
Net Income Margin (TTM):
-11.66%
Return On Equity:
--
Return On Invested Capital:
-141.04%
Operating Margin:
-8.78%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $118.3M | $135.8M | $193.1M | $38.6M | $53.4M | |
| Gross Profit | $98.2M | $118.2M | $173.1M | $33.8M | $48.4M | |
| Operating Income | -$46.5M | -$19.2M | -$19.3M | -$4.6M | -$4.7M | |
| EBITDA | -$44M | -$13.4M | -$10.1M | -$2.8M | -$2.1M | |
| Diluted EPS | -$1.80 | -$0.98 | -$0.64 | -$0.20 | -$0.14 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.7M | $14.1M | $13M | $24.9M | $48.7M | |
| Total Assets | $5.4M | $16.4M | $33.4M | $40.7M | $72.6M | |
| Current Liabilities | $9.4M | $19.9M | $24.9M | $32.5M | $59M | |
| Total Liabilities | $13.4M | $31M | $30.3M | $51.8M | $78.5M | |
| Total Equity | -$8M | -$14.7M | $3.1M | -$11.1M | -$6M | |
| Total Debt | $1.8M | $10.9M | -- | $19.3M | $18.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$26.8M | $1.1M | $21.7M | $1.1M | $6.2M | |
| Cash From Investing | -$13.7M | -$8.3M | -$11M | -$2.4M | -$3.5M | |
| Cash From Financing | $36.9M | $16.6M | $11.7M | $4.7M | -$825.6K | |
| Free Cash Flow | -$39.5M | -$7.2M | $10.6M | -$1.3M | $2.7M | |
LFMD
Sector
Market Cap
$218.3M
$43.9M
Price % of 52-Week High
39.13%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-37%
-29.11%
Beta (5-Year)
1.376
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-13.8%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$5.43
200-day SMA
Sell
Level
$7.02
Bollinger Bands (100)
Sell
Level
4.61 - 5.99
Chaikin Money Flow
Sell
Level
-18.2M
20-day SMA
Sell
Level
$5.83
Relative Strength Index (RSI14)
Sell
Level
41.17
ADX Line
Sell
Level
13.78
Williams %R
Neutral
Level
-74.7475
50-day SMA
Sell
Level
$5.34
MACD (12, 26)
Sell
Level
-0.10
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
34.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.418)
Sell
CA Score
(Annual)
Level (-3.0684)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.3051)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Stock Forecast FAQ
In the current month, LFMD has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The LFMD average analyst price target in the past 3 months is $12.00.
-
Where Will LifeMD Stock Be In 1 Year?
According to analysts, the consensus estimate is that LifeMD share price will rise to $12.00 per share over the next 12 months.
-
What Do Analysts Say About LifeMD?
Analysts are divided on their view about LifeMD share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that LifeMD is a Sell and believe this share price will drop from its current level to $7.00.
-
What Is LifeMD's Price Target?
The price target for LifeMD over the next 1-year time period is forecast to be $12.00 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is LFMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for LifeMD is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LFMD?
You can purchase shares of LifeMD via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase LifeMD shares.
-
What Is The LifeMD Share Price Today?
LifeMD was last trading at $5.00 per share. This represents the most recent stock quote for LifeMD. Yesterday, LifeMD closed at $5.04 per share.
-
How To Buy LifeMD Stock Online?
In order to purchase LifeMD stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
